Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yifeng Jing

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Medical Oncology (Northwood, London, England)|March 15, 2014
Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resectionBangmin Han, Shengjie Liang, Yifeng Jing, et al.
International Journal of Clinical and Experimental Pathology|January 23, 2020
Androgen receptor antagonist bicalutamide induces autophagy and apoptosis via ULK2 upregulation in human bladder cancer cellsKuiyuan Hao, Sheng Zhao, Di Cui, et al.
World Journal of Urology|September 9, 2018
Thulium laser enucleation versus thulium laser resection of the prostate for prevention of bladder neck contracture in a small prostate: a prospective randomized trialQian Sun, Wenhuan Guo, Di Cui, et al.
World Journal of Urology|August 6, 2013
A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up resultsDi Cui, Feng Sun, Jian Zhuo, et al.
Urologia Internationalis|February 14, 2015
Intra-arterial chemotherapy for muscle-invasive bladder cancer following transurethral resectionShengjie Liang, Qingsong Zou, Bangmin Han, et al.
BMC Complementary Medicine and Therapies|May 18, 2020
Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signalingYu Dong, Jiakuan Liu, Zesheng Xue, et al.
The Prostate|March 27, 2015
FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cellsWenhuan Guo, Anne L Keener, Yifeng Jing, et al.
Oncotarget|January 7, 2020
Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cellsXinpei Yu, Junkui Ai, Liquan Cai, et al.
The Prostate|July 17, 2018
Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cellsTiejun Yang, Yifeng Jing, Jun Dong, et al.
Oncotarget|April 9, 2016
Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cellsXinpei Yu, Junkui Ai, Liquan Cai, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Medical Oncology (Northwood, London, England)|March 15, 2014
Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resectionBangmin Han, Shengjie Liang, Yifeng Jing, et al.
International Journal of Clinical and Experimental Pathology|January 23, 2020
Androgen receptor antagonist bicalutamide induces autophagy and apoptosis via ULK2 upregulation in human bladder cancer cellsKuiyuan Hao, Sheng Zhao, Di Cui, et al.
World Journal of Urology|September 9, 2018
Thulium laser enucleation versus thulium laser resection of the prostate for prevention of bladder neck contracture in a small prostate: a prospective randomized trialQian Sun, Wenhuan Guo, Di Cui, et al.
World Journal of Urology|August 6, 2013
A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up resultsDi Cui, Feng Sun, Jian Zhuo, et al.
Urologia Internationalis|February 14, 2015
Intra-arterial chemotherapy for muscle-invasive bladder cancer following transurethral resectionShengjie Liang, Qingsong Zou, Bangmin Han, et al.
BMC Complementary Medicine and Therapies|May 18, 2020
Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signalingYu Dong, Jiakuan Liu, Zesheng Xue, et al.
The Prostate|March 27, 2015
FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cellsWenhuan Guo, Anne L Keener, Yifeng Jing, et al.
Oncotarget|January 7, 2020
Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cellsXinpei Yu, Junkui Ai, Liquan Cai, et al.
The Prostate|July 17, 2018
Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cellsTiejun Yang, Yifeng Jing, Jun Dong, et al.
Oncotarget|April 9, 2016
Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cellsXinpei Yu, Junkui Ai, Liquan Cai, et al.
Pageof 5